Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
1.05
-0.03 (-2.78%)
At close: Sep 30, 2022 4:00 PM
1.14
+0.09 (8.57%)
After-hours: Sep 30, 2022 6:33 PM EDT
-2.78%
Market Cap 10.87M
Revenue (ttm) n/a
Net Income (ttm) -1.85M
Shares Out 10.35M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,264
Open 1.04
Previous Close 1.08
Day's Range 1.02 - 1.14
52-Week Range 1.03 - 7.12
Beta 0.31
Analysts n/a
Price Target 7.91 (+653.3%)
Earnings Date Aug 15, 2022

About BBLG

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgi... [Read more...]

Industry Medical Devices
Founded 2004
Employees 2
Stock Exchange NASDAQ
Ticker Symbol BBLG
Full Company Profile

Financial Performance

Financial Statements

News

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company's preside...

6 months ago - Business Wire

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with MTF B...

6 months ago - Business Wire

BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today

Today, investors in Bone Biologics and BBLG stock are seeing some serious gains as investors dive into niche small caps. The post BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today ap...

8 months ago - InvestorPlace

Why Are Bone Biologics Shares Surging On Monday?

Newly listed Bone Biologics Corporation (NASDAQ: BBLG) shares are surging after the Company announced to present at the H.C. Wainwright BioConnect Virtual Conference.

8 months ago - Benzinga

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company's preside...

8 months ago - Business Wire

BBLG Stock Alert: What Is Going on With Bone Biologics Today?

The share price of BBIG stock, representing a little-known biotech company, is taking off today. Here's what you need to know.

10 months ago - InvestorPlace

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #BoneBiologics--Bone Biologics Corp. (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, toda...

11 months ago - Business Wire

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

JERSEY CITY, N.J., Oct. 15, 2021 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the completion of an underwritten public o...

11 months ago - PRNewsWire

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisti...

JERSEY CITY, N.J., Oct. 13, 2021 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the pricing of an underwritten public offe...

11 months ago - PRNewsWire

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Re...

BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #BoneBiologics--Bone Biologics Corp. (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, toda...

11 months ago - Business Wire